Pdt Partners, LLC Emergent Bio Solutions Inc. Transaction History

Pdt Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$1.86 - $6.98 $86,270 - $323,746	46,382 New	46,382 $316,000
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $502,109 - $894,749	-24,993 Reduced 59.7%	16,873 $354,000
Q2 2022 Aug 15, 2022	BUY	$27.42 - $43.63 $415,933 - $661,823	15,169 Added 56.82%	41,866 $1.3 Million
Q1 2022 May 16, 2022	BUY	$36.48 - $52.22 $973,906 - $1.39 Million	26,697 New	26,697 $1.1 Million

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $463M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.